Journal of Pathology, Communicable Diseases and Preventive Medicines

Authors: Dr. Anjali Mehra, Mr. Rohan Deshpande

ABSTRACT: Post-marketing surveillance (PMS) plays a vital role in monitoring the safety, efficacy, and quality of pharmaceuticals after their introduction to the market. Despite rigorous preclinical and clinical trials, rare or long-term adverse effects may only become evident once medicines are used in larger and more diverse populations. PMS ensures timely identification, reporting, and mitigation of risks associated with drug usage. This paper examines the role of PMS in enhancing drug safety, explores the tools and methodologies employed, and highlights challenges and opportunities for improving pharmacovigilance systems globally and in India. Emphasis is placed on regulatory frameworks, data collection systems, patient participation, and technological integration for better decision-making in public health.

KEYWORDS: Post-Marketing Surveillance, Pharmacovigilance, Drug Safety, Adverse Drug Reactions, Regulatory Frameworks, Public Health